{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:34:41Z","timestamp":1787589281213,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni-Suef University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118297","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:44:41Z","timestamp":1761201881000},"page":"118297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Synthesis and in silico studies of novel thiophene\u2013celecoxib hybrid with excellent cardiotoxicity and nephrotoxicity safety profiles"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-3563","authenticated-orcid":false,"given":"Eman K.A.","family":"Abdelall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe F.","family":"Lamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen B.","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"El-Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Mishrif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2025.118297_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: new adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118297_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115549","article-title":"Synthesis of novel 3,5,6-trisubstituted 2-pyridone derivatives and evaluation for their anti-inflammatory activity","volume":"28","author":"Gon\u00e7alves","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib3","article-title":"Pyrazole as an anti-inflammatory scaffold: a comprehensive review","author":"Kaur","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.ejmech.2025.118297_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103540","article-title":"New pyrazole derivatives possessing amino\/methanesulphonyl pharmacophore with good gastric safety profile: design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies","volume":"95","author":"Abdellatif","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2025.118297_bib5","article-title":"Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2\/LOX inhibitors","volume":"351","author":"Lamie","year":"2018","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2025.118297_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bioorg.2018.05.018","article-title":"Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: anti-inflammatory, analgesic activities and docking study","volume":"80","author":"Labib","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103441","article-title":"Synthesis and biological evaluations of novel isoxazoles and furoxan derivative as anti-inflammatory agents","volume":"94","author":"Abdelall","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2016.04.049","article-title":"Synthesis of new thiazolo-celecoxib analogues as dual cyclooxygenase-2\/15-lipoxygenase inhibitors: determination of regio-specific different pyrazole cyclization by 2D NMR","volume":"118","author":"Abdelall","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2016.12.030","article-title":"Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: confirmation of regiospecific pyrazole cyclization by HMBC","volume":"127","author":"Elshemy","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142338","article-title":"Molecular docking, ADME study, cardiovascular biomarkers and gastric safety of new pyrazoles as selective anti-inflammatory agents","volume":"1340","author":"Abdelall","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118297_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.363","article-title":"Arachidonic acid metabolism in health and disease","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2025.118297_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132835","article-title":"Anti-inflammatory drugs in patients with ischemic heart disease","volume":"10","author":"Pello L\u00e1zaro","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2025.118297_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00402-006-0243-1","article-title":"Rofecoxib inhibits heterotopic ossification after total hip arthroplasty","volume":"127","author":"van der Heide","year":"2007","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"10.1016\/j.ejmech.2025.118297_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ejmech.2016.08.013","article-title":"Novel N-substituted indole schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: synthesis, biological activities in vitro and docking study","volume":"123","author":"Lamie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2145283","article-title":"Novel N-methylsulfonyl-indole derivatives: biological activity and COX-2\/5-LOX inhibitory effect with improved gastro protective profile and reduced cardio vascular risks","volume":"38","author":"Philoppes","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib16","first-page":"11693","article-title":"Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl acad. Sci. USA","volume":"vol. 90","author":"Mitchell","year":"1994"},{"key":"10.1016\/j.ejmech.2025.118297_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130554","article-title":"Design, synthesis of new anti-inflammatory agents with a pyrazole core: COX-1\/COX-2 inhibition assays, anti-inflammatory, ulcerogenic, histopathological, molecular modeling, and ADME studies","volume":"1240","author":"Abdellatif","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14756366.2017.1326110","article-title":"Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study","volume":"32","author":"Lamie","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104418","article-title":"Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: anti-inflammatory activity, histopatholgical profile and in-silico studies","volume":"105","author":"Abdellatif","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104308","article-title":"Novel tetrazole-based selective COX-2 inhibitors: design, synthesis, anti-inflammatory activity, evaluation of PGE(2), TNF-\u03b1, IL-6 and histopathological study","volume":"104","author":"Labib","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118297_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","article-title":"Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs","volume":"327","author":"Allison","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118297_bib22","first-page":"2521","volume":"10","author":"Amin","year":"2018","journal-title":"Anti-inflammatory indomethacin analogs endowed with preferential COX-2 inhibitory activity"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118297_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.118297_bib24","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.bmcl.2016.04.046","article-title":"Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: determination of region-specific pyrazole ring formation by NOESY","volume":"26","author":"Abdelall","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118297_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106787","article-title":"Methanesulfonamide derivatives as gastric safe anti-inflammatory agents: design, synthesis, selective COX-2 inhibitory activity, histopathological and histochemical studies","volume":"140","author":"Abdelall","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103301","article-title":"Synthesis and biological evaluation of tetrazole derivatives as TNF-\u03b1, IL-6 and COX-2 inhibitors with antimicrobial activity: computational analysis, molecular modeling study and region-specific cyclization using 2D NMR tools","volume":"92","author":"Lamie","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2017.1326110","article-title":"Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study","volume":"32","author":"Lamie","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/molecules200916620","article-title":"Design, synthesis and evaluation of novel phthalimide derivatives as in vitro anti-microbial, anti-oxidant and anti-inflammatory agents","volume":"20","author":"Lamie","year":"2015","journal-title":"Molecules"},{"issue":"6610","key":"10.1016\/j.ejmech.2025.118297_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118297_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105806","article-title":"Trimethoxyphenyl containing compounds: synthesis, biological evaluation, nitric oxide release, modeling, histochemical and histopathological studies","volume":"124","author":"Abdelall","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118297_bib31","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1021\/jm0402059","article-title":"Adverse cardiovascular effects of the coxibs","volume":"48","author":"Dogn\u00e9","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106080","article-title":"Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative","volume":"168","author":"Bekhit","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.118297_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bioorg.2018.03.011","article-title":"Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2\/5-LOX enzymes: histopathological and docking studies","volume":"78","author":"Abdelgawad","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104418","article-title":"Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: anti-inflammatory activity, histopatholgical profile and in-silico studies","volume":"105","author":"Abdellatif","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bioorg.2019.01.031","article-title":"COX-1\/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core","volume":"86","author":"Abdelall","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib36","doi-asserted-by":"crossref","DOI":"10.3109\/14756366.2015.1022174","article-title":"3-methyl-2-phenyl-1-substituted-indole derivatives as indomethacin analogs: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents","volume":"31","author":"Abdellatif","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118297_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor","volume":"38","author":"Davies","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2025.118297_bib38","first-page":"1","article-title":"Design, synthesis, and biological evaluation of 2-(4-(methylsulfonyl) phenyl) indole derivatives with promising COX-2 inhibitory activity","volume":"8","author":"Shaker","year":"2018","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.118297_bib39","unstructured":"Abuo-Rahma Gel, D., et al., 1,2,4-Triazole\/oxime hybrids as new strategy for nitric oxide donors: synthesis, anti-inflammatory, Ulceroginicity and Antiproliferative Activities. (1768-3254 (Electronic))."},{"key":"10.1016\/j.ejmech.2025.118297_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bioorg.2017.06.003","article-title":"New 1,3,4-oxadiazole\/oxime hybrids: design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability","volume":"74","author":"Abd-Ellah","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib41","unstructured":"Mohassab, A.M., et al., Novel quinoline incorporating 1,2,4-triazole\/oxime hybrids: synthesis, molecular docking, anti-inflammatory, COX Inhibition, Ulceroginicity and Histopathological Investigations. (1090-2120 (Electronic))."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118297_bib42","article-title":"Nitric Oxide-NASIDS donor prodrugs as hybrid safe anti-inflammatory agents current","volume":"17","author":"Khaled","year":"2017","journal-title":"Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2014.02.033","article-title":"Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents","volume":"76","author":"Hassan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib44","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1016\/j.bmcl.2017.08.023","article-title":"Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids","volume":"27","author":"Abdelall","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118297_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ph3051530","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs): progress in small molecule drug development","volume":"3","author":"Rao","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118297_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142578","article-title":"Design, synthesis and biological evaluation of phenoxyacetic acid derivatives linked to pyrazole scaffold as PPAR-\u03b1\/\u03b3 agonists and COX-2 inhibitors with dual Antidiabetic\/anti-inflammatory activities","volume":"1340","author":"Fadaly","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118297_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116155","article-title":"Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: design, synthesis and biological activities","volume":"266","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115180","article-title":"4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: design, synthesis, and biological assessments","volume":"250","author":"Ragab","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117286","article-title":"Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents","volume":"286","author":"Song","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117340","article-title":"Optimization of pyrazole\/1,2,4-triazole as dual EGFR\/COX-2 inhibitors: design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis","volume":"287","author":"Kahk","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.02.023","article-title":"4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII","volume":"76","author":"Khloya","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118297_bib52","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.bmc.2014.10.018","article-title":"4-Functionalized 1, 3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII","volume":"22","author":"Ceruso","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118297_bib53","first-page":"39","article-title":"Synthesis, characterization and in vitro cytotoxic evaluation of some novel heterocyclic compounds bearing the indole ring","volume":"6","author":"Salman","year":"2016","journal-title":"Am. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0031-1297252","article-title":"Novel pyrazole derivatives as anticancer and radiosensitizing agents","volume":"62","author":"Aly","year":"2012","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118297_bib55","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.bmc.2012.01.032","article-title":"Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis","volume":"20","author":"Vujasinovi\u0107","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib56","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/14756360802188404","article-title":"Synthesis of some pyrazolyl benzenesulfonamide derivatives as dual anti-inflammatory antimicrobial agents","volume":"24","author":"Bekhit","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118297_bib57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3109\/14756366.2016.1158168","article-title":"Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore","volume":"31","author":"Abdellatif","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2025.118297_bib58","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1016\/j.bmcl.2011.05.105","article-title":"Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives","volume":"21","author":"Nagarapu","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118297_bib59","series-title":"Nanostructured Biomaterials: Basic Structures and Applications","first-page":"229","article-title":"Overview on biological activities of pyrazole derivatives","author":"Kabi","year":"2022"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/cb0500042","article-title":"High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis","volume":"1","author":"Sullivan","year":"2006","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118297_bib61","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ejmech.2009.12.042","article-title":"Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles","volume":"45","author":"Ragavan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2011.12.011","article-title":"Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents","volume":"48","author":"Xu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118297_bib63","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1155\/2009\/247209","article-title":"Synthesis, spectral and microbial studies of some novel schiff base derivatives of 4-methylpyridin-2-amine","volume":"6","author":"Vora","year":"2009","journal-title":"J. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/22113525113119990117","article-title":"Synthesis and evaluation of N-substituted thiazolidine-2, 4-dione containing pyrazole as a potent antimicrobial agents","volume":"12","author":"Desai","year":"2014","journal-title":"Anti-infective agents"},{"key":"10.1016\/j.ejmech.2025.118297_bib65","article-title":"Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue","volume":"9","author":"Varga","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2025.118297_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118297_bib67","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J. Pharm. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118297_bib68","article-title":"Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects","volume":"94","author":"Batlouni","year":"2010","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.ejmech.2025.118297_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117631","article-title":"Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: a review","volume":"251","author":"Arora","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118297_bib70","first-page":"30647","article-title":"NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead","volume":"14","author":"Khalil","year":"2024","journal-title":"Roy. Soc. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118297_bib71","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1073\/pnas.0913377107","article-title":"Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition","volume":"107","author":"Limongelli","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118297_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135041","article-title":"A review of biologically active oxime ethers","volume":"28","author":"Kosmalski","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118297_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108429","article-title":"Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 mpro inhibitory activity: antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities","volume":"160","author":"Abdelall","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib74","series-title":"Clinical Chemistry, Immunology and Laboratory Quality Control","first-page":"149","article-title":"Chapter 8 - cardiac markers","author":"Dasgupta","year":"2021"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118297_bib75","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejmech.2025.118297_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2023.105253","article-title":"High serum lactate dehydrogenase as a predictor of cardiac insufficiency at follow-up in elderly patients with acute myocardial infarction","volume":"117","author":"Zhang","year":"2024","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.ejmech.2025.118297_bib77","article-title":"Abstract 15577: elevated serum aspartate transaminase as a predictor of early mortality in patients with Non-ST-Segment elevation myocardial infarction","volume":"136","author":"Arora","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2025.118297_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5455\/medscience.2020.09.203","article-title":"ADME predictions and molecular docking study of some compounds and drugs as potential inhibitors of COVID-19 main protease: a virtual study as comparison of computational results","volume":"10","author":"Uslu","year":"2021","journal-title":"Med. Sci. Int. Med. J."},{"key":"10.1016\/j.ejmech.2025.118297_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105335","article-title":"Design, synthesis, stereochemical determination, molecular docking study, in silico pre-ADMET prediction and anti-proliferative activities of indole-pyrimidine derivatives as Mcl-1 inhibitors","volume":"116","author":"Lamie","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118297_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/ijtdh\/2021\/v42i1130492","article-title":"In silico ADME\/T properties of quinine derivatives using SwissADME and pkCSM webservers","volume":"42","author":"Mvondo","year":"2021","journal-title":"Int. J. Tropical Dis. Health"},{"key":"10.1016\/j.ejmech.2025.118297_bib82","series-title":"Asked questions","author":"SwissADME","year":"2025"},{"issue":"20","key":"10.1016\/j.ejmech.2025.118297_bib83","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118297_bib84","doi-asserted-by":"crossref","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib85","first-page":"864","volume":"35","author":"Lamie","year":"2022","journal-title":"2-Thiopyrimidine\/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3\/STAT5a inhibitors"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib86","first-page":"135","article-title":"Calculation of molecular lipophilicity and drug likeness for few heterocycles","volume":"26","author":"Lalitha","year":"2010","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37134\/ejsmt.vol4.2.1.2017","article-title":"In silico assessment of drug-like properties of phytocannabinoids in Cannabis sativa","volume":"4","author":"Desa","year":"2017","journal-title":"Educatum. J. Sci. Math. Technol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118297_bib89","article-title":"Calculation of molecular lipophilicity and drug likeness for few heterocycles","volume":"26","author":"Lalitha","year":"2010","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118297_bib90","doi-asserted-by":"crossref","DOI":"10.61164\/rmnm.v6i1.2529","article-title":"Predictive evaluation of the toxicity and adverse effects of PLANTANONES a-d","volume":"6","author":"Sousa","year":"2024","journal-title":"Revista Multidisciplinar do Nordeste Mineiro"},{"key":"10.1016\/j.ejmech.2025.118297_bib91","first-page":"35","article-title":"In silico study by using ProTox-II webserver for oral acute toxicity, organ toxicity, immunotoxicity, genetic toxicity endpoints, nuclear receptor signalling and stress response pathways of synthetic pyrethroids","author":"Ghosh","year":"2019","journal-title":"World Sci. News"},{"key":"10.1016\/j.ejmech.2025.118297_bib92","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0 - a webserver for the prediction of toxicity of chemicals","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ejmech.2025.118297_bib93","doi-asserted-by":"crossref","first-page":"W115","DOI":"10.1093\/nar\/gkac313","article-title":"BioTransformer 3.0\u2014a web server for accurately predicting metabolic transformation products","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118297_bib94","author":"Ahamad"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118297_bib95","first-page":"28","article-title":"A handbook on protein-ligand docking tool: autoDock4","volume":"4","author":"Ravi","year":"2016","journal-title":"Innovare J. Med. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:01:01Z","timestamp":1780909261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":94,"alternative-id":["S0223523425010621"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118297","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in silico studies of novel thiophene\u2013celecoxib hybrid with excellent cardiotoxicity and nephrotoxicity safety profiles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118297"}}